ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Nominations Open For Bristol-Myers Award; New Surgical Oncology Chair At South Florida

September 7, 1984

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

Appropriations 2014: Obama Plan Good News for NIH, Bad News For Some Oncologists

April 12, 2013

National Coalition An Education Group, Chairman Says

May 3, 1985

NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement.

September 29, 2000